Prognostic factors, treatment, and survival in cutaneous pleomorphic sarcoma
Limited information exists on the influence of demographics, tumor characteristics, and treatment on survival in cutaneous pleomorphic sarcoma (CPS).
Related Articles
Generalized pustular psoriasis: A consensus statement from the National Psoriasis Foundation
Generalized pustular psoriasis (GPP) is a serious, immune-mediated inflammatory skin disease with significant morbidity and mortality. Estimates of GPP prevalence vary between 1.8 and 124…
Modified linear closure with standing cone management: An alternative to the purse string suture
Compared to fusiform excisions, purse-string closures eliminate excision of extraneous tissue, with the resulting scar typically shorter than the original defect.1 However, purse-string closures rely…
Incidence and profile of skin cancers in patients following ultraviolet phototherapy without psoralens: A retrospective cohort study
Psoralen + ultraviolet-A (PUVA) is associated with photocarcinogenesis. However, carcinogenic risk with other ultraviolet phototherapies remains unclear.
Subcision modification to prevent intraoperative blood spillage and to keep the needle aligned
The traditional subcision is often associated with the spurting of blood from the needle hub and rotation of the beveled end of the needle. These…
The road to publication: Advice from journal editors
Anyone who invests their time in writing a scientific manuscript will want a decent chance of it being accepted for publication (Table I).1,2 We present practical…
Alopecia – New building blocks
Hair loss is devastating to the patient, but the diagnosis and treatment of alopecia are also difficult for primary care providers and even dermatologists. Given…
Guidance on screening magnetic resonance imaging decisions for congenital melanocytic nevi
To the Editor: We appreciate the interest in our study and comment from Dr Kinsler and are grateful for her leadership in characterizing the genetics…
Impact of dupilumab on patch test results and allergic contact dermatitis: A prospective multicenter study
Limited and conflicting data have been reported on the impact of dupilumab (DUPI) on patch test (PT) results and its efficacy against allergic contact dermatitis…